Genomictree Inc. (KOSDAQ:228760)

Genomictree Revenue

Genomictree had revenue of 842.32M KRW in the quarter ending June 30, 2026, a decrease of -51.06%. This brings the company's total for the last twelve months to 2.95B, down -17.13% year-over-year. In the year 2025, Genomictree had annual revenue of 3.76B with 59.17% growth. That makes Genomictree the 42,218th largest company in the world by revenue and 2,564th in South Korea.

• Revenue (ttm): 2.95B
• Revenue Growth: -17.13%
• P/S Ratio: 83.06
• Revenue / Employee: 37.30M
• Employees: 79
• Market Cap: 242.75B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Cancer Molecular Diagnosis Business 3.44B 91.6%
• Genomic Analysis and Other Business 316.82M 8.4%

By Geography

Chart

• Korea 2.75B 73.2%
• China 1.00B 26.6%
• Others 9.40M 0.2%

Fiscal year ended Dec 31, 2025 See the full Genomictree breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.76B	1.40B	59.17%
Dec 31, 2024	2.36B	-1.06B	-30.89%
Dec 31, 2023	3.42B	-26.45B	-88.56%
Dec 31, 2022	29.87B	24.73B	481.09%
Dec 31, 2021	5.14B	3.90B	314.87%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 31, 2026

Data Sources Report a data error